Table 3.
The comparison of laboratory findings of individuals with obesity according to their metabolic phenotypes
| Metabolic phenotype | ||||
|---|---|---|---|---|
| Metabolically unhealthy | Metabolically healthy | Total sample | ||
| Mean ± SD Median (min-max) |
Mean ± SD Median (min-max) |
Mean ± SD Median (min-max) |
p | |
| Fasting blood glucose (mg/dl) | 95.5 (71.0–144.0) | 91.0 (61.0–99.0) | 92.0 (61.0–144.0) | 0.016 |
| HbA1c (%) | 6.0 (4.7–8.0) | 5.4 (4.5–6.1) | 5.7 (4.5–8.0) | <0.001 |
| c-peptide (ng/ml) | 3.2 (1.9–7.6) | 2.6 (1.2–6.6) | 2.9 (1.2–7.6) | 0.01 |
| Insulin | 16.7 (2.7–93.4) | 14.8 (2.8–48.7) | 16.1 (2.7–93.4) | 0.35 |
| HOMA-IR | 3.9 (0.6–33.2) | 3.38 (0.6–33.2) | 3.7 (0.6–33.2) | 0.29 |
| Total cholesterol (mg/dl) | 185.0 (11.3–254.0) | 173.0 (99.0–248.0) | 177.0 (11.3–254.0) | 0.06 |
| HDL (mg/dl) | 42.6 ± 9.2 | 56.6 ± 11.2 | 49.4 ± 12.4 | <0.001 |
| LDL (mg/dl) | 114.2 ± 27.07 | 98.3 ± 29.9 | 106.4 ± 29.5 | 0.003 |
| TG (mg/dl) | 146.0 (53.0–608.0) | 98.0 (5.0–155.0) | 118.5 (53.0–608.0) | <0.001 |
| Vitamin B12 (pg/ml) | 294.0 (170.0–851.0) | 324.5 (157.0–694.0) | 320.0 (157–851.0) | 0.49 |
| Urea (mg/dl) | 23.7 ± 6.8 | 23.07 ± 5.5 | 23.4 ± 6.2 | 0.64 |
| Creatinine (mg) | 0.8 ± 0.9 | 0.6 ± 0.1 | 0.7 ± 0.6 | 0.10 |
| Uric acid (mg/dl) | 5.05 ± 1.09 | 4.7 ± 1.1 | 4.9 ± 1.1 | 0.11 |
| TSH (mIU/L) | 2.08 ± 1.03 | 2.4 ± 1.4 | 2.2 ± 1.2 | 0.25 |
| Vitamin D (IU) | 13.0 (3.0–43.0) | 13.6 (4.9–30.0) | 13.0 (3.0–43.0) | 0.63 |
| İrisin (conc.pg/ml) | 144.0 (10.1–3364.0) | 158.1 (3.3–2666.0) | 154.0 (3.3–3364.0) | 0.73 |
| NRG-4 (ng/ml) | 0.7 (0.09–10.2) | 0.7 (0.04–4.5) | 0.7 (0.04–10.2) | 0.39 |
| FGF-21 (conc.pg/ml) | 25.4 (0.4–291.3) | 38.9 (1.8–461.8) | 27.2 (0.4–461.8) | 0.32 |
SD Standard Deviation, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, HDL High Density Lipoprotein, LDL Low Density Lipoprotein, TG Triglyceride, TSH Thyroid Stimulating Hormone, NRG-4 Neuregulin-4, FGF-21 Fibroblast Growth Factor
Statistically significant results were shown in bold font